Aurobindo Pharma gets European Commission’s nod to market cancer drug, Dazublys
- Posted on July 2, 2025
- By Financial Express
- 1 Views
Aurobindo Pharma gets European Commission’s nod to market cancer drug, Dazublys
CuraTeQ Biologics, a wholly owned subsidiary of the company dedicated to oncology and immunology segments, has received authorisation from the European authorities.
